TY - JOUR AU - Urban, N. AU - Drescher, C. PY - 2008 DA - 2008// TI - Potential and limitations in early diagnosis of ovarian cancer JO - Adv Exp Med Biol VL - 622 UR - https://doi.org/10.1007/978-0-387-68969-2_1 DO - 10.1007/978-0-387-68969-2_1 ID - Urban2008 ER - TY - JOUR AU - Weisenberger, D. J. PY - 2014 DA - 2014// TI - Characterizing DNA methylation alterations from the cancer genome atlas JO - J Clin Invest VL - 124 UR - https://doi.org/10.1172/JCI69740 DO - 10.1172/JCI69740 ID - Weisenberger2014 ER - TY - JOUR AU - Liu, R. PY - 2013 DA - 2013// TI - Ten-eleven translocation-2 (TET2) is a master regulator of smooth muscle cell plasticity JO - Circulation VL - 128 UR - https://doi.org/10.1161/CIRCULATIONAHA.113.002887 DO - 10.1161/CIRCULATIONAHA.113.002887 ID - Liu2013 ER - TY - JOUR AU - An, J. AU - Rao, A. AU - Ko, M. PY - 2017 DA - 2017// TI - TET family dioxygenases and DNA demethylation in stem cells and cancers JO - Exp Mol Med VL - 49 UR - https://doi.org/10.1038/emm.2017.5 DO - 10.1038/emm.2017.5 ID - An2017 ER - TY - JOUR AU - Koh, K. P. PY - 2011 DA - 2011// TI - Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells JO - Cell Stem Cell VL - 8 UR - https://doi.org/10.1016/j.stem.2011.01.008 DO - 10.1016/j.stem.2011.01.008 ID - Koh2011 ER - TY - JOUR AU - Ye, Z. PY - 2016 DA - 2016// TI - TET3 inhibits TGF-beta1-induced epithelial-mesenchymal transition by demethylating miR-30d precursor gene in ovarian cancer cells JO - J Exp Clin Cancer Res VL - 35 UR - https://doi.org/10.1186/s13046-016-0350-y DO - 10.1186/s13046-016-0350-y ID - Ye2016 ER - TY - JOUR AU - Han, X. PY - 2017 DA - 2017// TI - TET1 promotes cisplatin-resistance via demethylating the vimentin promoter in ovarian cancer JO - Cell Biol Int VL - 41 UR - https://doi.org/10.1002/cbin.10734 DO - 10.1002/cbin.10734 ID - Han2017 ER - TY - JOUR AU - Tan, P. K. PY - 2003 DA - 2003// TI - Evaluation of gene expression measurements from commercial microarray platforms JO - Nucleic Acids Res VL - 31 UR - https://doi.org/10.1093/nar/gkg763 DO - 10.1093/nar/gkg763 ID - Tan2003 ER - TY - JOUR AU - Sims, A. H. PY - 2008 DA - 2008// TI - The removal of multiplicative, systematic bias allows integration of breast cancer gene expression datasets - improving meta-analysis and prediction of prognosis JO - BMC Med Genet VL - 1 ID - Sims2008 ER - TY - JOUR AU - Rhodes, D. R. PY - 2007 DA - 2007// TI - Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles JO - Neoplasia VL - 9 UR - https://doi.org/10.1593/neo.07112 DO - 10.1593/neo.07112 ID - Rhodes2007 ER - TY - JOUR AU - Barrett, T. AU - Edgar, R. PY - 2006 DA - 2006// TI - Gene expression omnibus: microarray data storage, submission, retrieval, and analysis JO - Methods Enzymol VL - 411 UR - https://doi.org/10.1016/S0076-6879(06)11019-8 DO - 10.1016/S0076-6879(06)11019-8 ID - Barrett2006 ER - TY - JOUR AU - Gyorffy, B. PY - 2010 DA - 2010// TI - An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients JO - Breast Cancer Res Treat VL - 123 UR - https://doi.org/10.1007/s10549-009-0674-9 DO - 10.1007/s10549-009-0674-9 ID - Gyorffy2010 ER - TY - JOUR AU - Mizuno, H. PY - 2009 DA - 2009// TI - PrognoScan: a new database for meta-analysis of the prognostic value of genes JO - BMC Med Genet VL - 2 ID - Mizuno2009 ER - TY - JOUR AU - Szklarczyk, D. PY - 2015 DA - 2015// TI - STRING v10: protein-protein interaction networks, integrated over the tree of life JO - Nucleic Acids Res VL - 43 UR - https://doi.org/10.1093/nar/gku1003 DO - 10.1093/nar/gku1003 ID - Szklarczyk2015 ER - TY - JOUR AU - Franceschini, A. PY - 2013 DA - 2013// TI - STRING v9.1: protein-protein interaction networks, with increased coverage and integration JO - Nucleic Acids Res VL - 41 ID - Franceschini2013 ER - TY - JOUR AU - Cerami, E. PY - 2012 DA - 2012// TI - The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data JO - Cancer Discov VL - 2 UR - https://doi.org/10.1158/2159-8290.CD-12-0095 DO - 10.1158/2159-8290.CD-12-0095 ID - Cerami2012 ER - TY - JOUR AU - Gao, J. PY - 2013 DA - 2013// TI - Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal JO - Sci Signal VL - 6 UR - https://doi.org/10.1126/scisignal.2004088 DO - 10.1126/scisignal.2004088 ID - Gao2013 ER - TY - JOUR AU - Hendrix, N. D. PY - 2006 DA - 2006// TI - Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-05-3694 DO - 10.1158/0008-5472.CAN-05-3694 ID - Hendrix2006 ER - TY - JOUR AU - Adib, T. R. PY - 2004 DA - 2004// TI - Predicting biomarkers for ovarian cancer using gene-expression microarrays JO - Br J Cancer VL - 90 UR - https://doi.org/10.1038/sj.bjc.6601603 DO - 10.1038/sj.bjc.6601603 ID - Adib2004 ER - TY - JOUR AU - Lu, K. H. PY - 2004 DA - 2004// TI - Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis JO - Clin Cancer Res VL - 10 UR - https://doi.org/10.1158/1078-0432.CCR-03-0409 DO - 10.1158/1078-0432.CCR-03-0409 ID - Lu2004 ER - TY - JOUR AU - Bonome, T. PY - 2008 DA - 2008// TI - A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-6595 DO - 10.1158/0008-5472.CAN-07-6595 ID - Bonome2008 ER - TY - JOUR AU - Mok, S. C. PY - 2009 DA - 2009// TI - A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2 JO - Cancer Cell VL - 16 UR - https://doi.org/10.1016/j.ccr.2009.10.018 DO - 10.1016/j.ccr.2009.10.018 ID - Mok2009 ER - TY - JOUR AU - Konstantinopoulos, P. A. PY - 2010 DA - 2010// TI - Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.27.5719 DO - 10.1200/JCO.2009.27.5719 ID - Konstantinopoulos2010 ER - TY - JOUR AU - Marchion, D. C. PY - 2011 DA - 2011// TI - BAD phosphorylation determines ovarian cancer chemosensitivity and patient survival JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-11-0735 DO - 10.1158/1078-0432.CCR-11-0735 ID - Marchion2011 ER - TY - JOUR AU - Mateescu, B. PY - 2011 DA - 2011// TI - miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response JO - Nat Med VL - 17 UR - https://doi.org/10.1038/nm.2512 DO - 10.1038/nm.2512 ID - Mateescu2011 ER - TY - JOUR AU - King, E. R. PY - 2011 DA - 2011// TI - The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer JO - Am J Surg Pathol VL - 35 UR - https://doi.org/10.1097/PAS.0b013e318212ae22 DO - 10.1097/PAS.0b013e318212ae22 ID - King2011 ER - TY - JOUR AU - Ferriss, J. S. PY - 2012 DA - 2012// TI - Multi-gene expression predictors of single drug responses to adjuvant chemotherapy in ovarian carcinoma: predicting platinum resistance JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0030550 DO - 10.1371/journal.pone.0030550 ID - Ferriss2012 ER - TY - JOUR AU - Yoshihara, K. PY - 2012 DA - 2012// TI - High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-11-2725 DO - 10.1158/1078-0432.CCR-11-2725 ID - Yoshihara2012 ER - TY - JOUR AU - Yeung, T. L. PY - 2013 DA - 2013// TI - TGF-beta modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment JO - Cancer Res VL - 73 UR - https://doi.org/10.1158/0008-5472.CAN-13-0023 DO - 10.1158/0008-5472.CAN-13-0023 ID - Yeung2013 ER - TY - JOUR AU - Wu, Y. H. PY - 2014 DA - 2014// TI - COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer JO - Oncogene VL - 33 UR - https://doi.org/10.1038/onc.2013.307 DO - 10.1038/onc.2013.307 ID - Wu2014 ER - TY - JOUR AU - Koti, M. PY - 2013 DA - 2013// TI - Identification of the IGF1/PI3K/NF kappaB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer JO - BMC Cancer VL - 13 UR - https://doi.org/10.1186/1471-2407-13-549 DO - 10.1186/1471-2407-13-549 ID - Koti2013 ER - TY - JOUR AU - Yeung, T. L. PY - 2017 DA - 2017// TI - ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells JO - Oncotarget VL - 8 UR - https://doi.org/10.18632/oncotarget.15208 DO - 10.18632/oncotarget.15208 ID - Yeung2017 ER - TY - JOUR AU - Lisowska, K. M. PY - 2014 DA - 2014// TI - Gene expression analysis in ovarian cancer - faults and hints from DNA microarray study JO - Front Oncol VL - 4 UR - https://doi.org/10.3389/fonc.2014.00006 DO - 10.3389/fonc.2014.00006 ID - Lisowska2014 ER - TY - JOUR AU - Uehara, Y. PY - 2015 DA - 2015// TI - Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0128066 DO - 10.1371/journal.pone.0128066 ID - Uehara2015 ER - TY - JOUR AU - Tothill, R. W. PY - 2008 DA - 2008// TI - Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome JO - Clin Cancer Res VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-08-0196 DO - 10.1158/1078-0432.CCR-08-0196 ID - Tothill2008 ER - TY - JOUR AU - Zhang, Y. W. PY - 2017 DA - 2017// TI - Acetylation enhances TET2 function in protecting against abnormal DNA methylation during oxidative stress JO - Mol Cell VL - 65 UR - https://doi.org/10.1016/j.molcel.2016.12.013 DO - 10.1016/j.molcel.2016.12.013 ID - Zhang2017 ER - TY - JOUR AU - Klonowska, K. PY - 2016 DA - 2016// TI - Oncogenomic portals for the visualization and analysis of genome-wide cancer data JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.6128 DO - 10.18632/oncotarget.6128 ID - Klonowska2016 ER - TY - JOUR AU - Patch, A. M. AU - Christie, E. L. AU - Etemadmoghadam, D. AU - Garsed, D. W. AU - George, J. AU - Fereday, S. PY - 2015 DA - 2015// TI - Whole-genome characterization of chemoresistant ovarian cancer JO - Nature VL - 521 UR - https://doi.org/10.1038/nature14410 DO - 10.1038/nature14410 ID - Patch2015 ER - TY - STD TI - Bell D, Berchuck A, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474(7353):609–15. ID - ref39 ER - TY - JOUR AU - Fang, F. PY - 2018 DA - 2018// TI - Genomic and epigenomic signatures in ovarian cancer associated with resensitization to platinum drugs JO - Cancer Res VL - 78 UR - https://doi.org/10.1158/0008-5472.CAN-17-1492 DO - 10.1158/0008-5472.CAN-17-1492 ID - Fang2018 ER - TY - JOUR AU - Peters, D. AU - Freund, J. AU - Ochs, R. L. PY - 2005 DA - 2005// TI - Genome-wide transcriptional analysis of carboplatin response in chemosensitive and chemoresistant ovarian cancer cells JO - Mol Cancer Ther VL - 4 UR - https://doi.org/10.1158/1535-7163.MCT-04-0311 DO - 10.1158/1535-7163.MCT-04-0311 ID - Peters2005 ER -